Home / Sandoz Inc. Recalls One Lot of Losartan Potassium and Hydrochlorothiazide Tablets Due to NDEA Impurities in API

Sandoz Inc. Recalls One Lot of Losartan Potassium and Hydrochlorothiazide Tablets Due to NDEA Impurities in API

According to the U.S. Food and Drug Administration (FDA), Sandoz Inc. issued a voluntary nationwide recall on one lot of Losartan Potassium Hydrochlorothiazide tablets, USP 100mg/25mg on Friday, November 9….

Recent Global Disruptions

EIGHTEENTH UPDATE: Supply Chain Disruptions Continue as Coronavirus Outbreak Worsens

Fire Engulfs Truck Carrying Fiat Spare Parts in Canapi, Sertao Alagoano, Brazil

Lactalis to Close its Milk Facility in Rockhampton, Queensland, Australia